|
US2669583A
(en)
*
|
|
1954-02-16 |
|
X-amroo-zralkoxbbenzamdjes |
|
US2006735A
(en)
*
|
1932-11-17 |
1935-07-02 |
Gen Aniline Works Inc |
Nitro-aryl amino-aryl amines
|
|
LU38172A1
(enExample)
*
|
1957-11-25 |
|
|
|
|
US3161564A
(en)
|
1960-10-03 |
1964-12-15 |
Salsbury S Lab Dr |
Veterinary composition containing halo-nitro-benzamides and methods of using same
|
|
US3228833A
(en)
*
|
1962-12-17 |
1966-01-11 |
Sterling Drug Inc |
Anticoccidial compositions and methods of using same
|
|
GB1493685A
(en)
*
|
1970-12-15 |
1977-11-30 |
May & Baker Ltd |
8-azapurinones
|
|
AR204004A1
(es)
|
1973-04-02 |
1975-11-12 |
Lilly Co Eli |
Procedimientos para preparar derivados de vinblastina leurosidina y leurocristina
|
|
FR2456731A1
(fr)
|
1979-05-16 |
1980-12-12 |
Choay Sa |
Nouveaux derives substitues d'ary
|
|
JPS6019790A
(ja)
|
1983-07-14 |
1985-01-31 |
Yakult Honsha Co Ltd |
新規なカンプトテシン誘導体
|
|
US5032617A
(en)
*
|
1985-05-03 |
1991-07-16 |
Sri International |
Substituted benzamide radiosensitizers
|
|
US5041653A
(en)
|
1985-05-03 |
1991-08-20 |
Sri International |
Substituted benzamide radiosensitizers
|
|
US5215738A
(en)
*
|
1985-05-03 |
1993-06-01 |
Sri International |
Benzamide and nicotinamide radiosensitizers
|
|
US6407079B1
(en)
*
|
1985-07-03 |
2002-06-18 |
Janssen Pharmaceutica N.V. |
Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
|
|
DE3750093T2
(de)
*
|
1986-01-17 |
1995-01-26 |
Daniel G Miller |
Test zur Feststellung der Empfänglichkeit für DNS-assoziierte Krankheiten.
|
|
US5283352A
(en)
*
|
1986-11-28 |
1994-02-01 |
Orion-Yhtyma Oy |
Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
|
|
US5223608A
(en)
*
|
1987-08-28 |
1993-06-29 |
Eli Lilly And Company |
Process for and intermediates of 2',2'-difluoronucleosides
|
|
US4923885A
(en)
*
|
1988-08-19 |
1990-05-08 |
Merck & Co., Inc. |
5-amino-1-(4-naphthoylbenzyl)-1,2,3-triazole-4-carboxamides and analogs as antiproliferative agents
|
|
US5177075A
(en)
*
|
1988-08-19 |
1993-01-05 |
Warner-Lambert Company |
Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process
|
|
EP0494231A4
(en)
|
1989-09-26 |
1992-09-16 |
The Regents Of The University Of California |
6-amino-1,2-benzopyrones useful for treatment of viral diseases
|
|
US5719151A
(en)
*
|
1990-05-04 |
1998-02-17 |
Shall; Sydney |
Substituted benzene compounds
|
|
US5633282A
(en)
*
|
1990-05-25 |
1997-05-27 |
British Technology Group Limited |
Inhibition of viral infection
|
|
US5637618A
(en)
*
|
1990-06-01 |
1997-06-10 |
Bioresearch, Inc. |
Specific eatable taste modifiers
|
|
US5232735A
(en)
|
1990-06-01 |
1993-08-03 |
Bioresearch, Inc. |
Ingestibles containing substantially tasteless sweetness inhibitors as bitter taste reducers or substantially tasteless bitter inhibitors as sweet taste reducers
|
|
US5631038A
(en)
*
|
1990-06-01 |
1997-05-20 |
Bioresearch, Inc. |
Specific eatable taste modifiers
|
|
HUT70024A
(en)
*
|
1990-09-28 |
1995-09-28 |
Smithkline Beecham Corp |
Process for preparing water soluble camptothecin analogs
|
|
US5484951A
(en)
*
|
1990-10-19 |
1996-01-16 |
Octamer, Incorporated |
5-iodo-6-amino-6-nitroso-1,2-benzopyrones useful as cytostatic and antiviral agents
|
|
US5243050A
(en)
|
1990-12-20 |
1993-09-07 |
North Carolina State University |
Alkylpyridone DE ring intermediates useful for the manufacture of camptothecin and camptothecin analogs
|
|
US5247089A
(en)
|
1990-12-20 |
1993-09-21 |
North Carolina State University |
Method of making intermediates useful for the manufacture of camptothecin and camptothecin analogs
|
|
US5191082A
(en)
*
|
1990-12-20 |
1993-03-02 |
North Carolina State University |
Camptothecin intermediate and method of making camptothecin intermediates
|
|
US5200524A
(en)
*
|
1990-12-20 |
1993-04-06 |
North Carolina State University |
Camptothecin intermediates and method of making same
|
|
US5162532A
(en)
|
1990-12-20 |
1992-11-10 |
North Carolina State University |
Intermediates and method of making camptothecin and camptothecin analogs
|
|
JPH06504791A
(ja)
|
1991-04-10 |
1994-06-02 |
オクタマー，インコーポレイティド |
レトロウィルス複製の阻害のための方法
|
|
US5652260A
(en)
|
1991-10-22 |
1997-07-29 |
Octamer, Inc. |
Adenosine diphosphoribose polymerase binding nitroso aromatic compound useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents
|
|
US5516941A
(en)
*
|
1991-10-22 |
1996-05-14 |
Octamer, Inc. |
Specific inactivators of "retroviral" (asymmetric) zinc fingers
|
|
US5473074A
(en)
|
1991-10-22 |
1995-12-05 |
Octamer, Incorporated |
Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents-54
|
|
US5464871A
(en)
|
1993-05-12 |
1995-11-07 |
Octamer, Inc. |
Aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents
|
|
US5482975A
(en)
*
|
1991-10-22 |
1996-01-09 |
Octamer, Inc. |
Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents
|
|
US5877185A
(en)
*
|
1991-10-22 |
1999-03-02 |
Octamer, Inc. |
Synergistic compositions useful as anti-tumor agents
|
|
FR2689009B1
(fr)
*
|
1992-03-25 |
1995-06-23 |
Oreal |
Utilisation en teinture, de metaphenylene-diamines soufrees, composition tinctoriale et procede de teinture, nouvelles metaphenylenediamines soufrees.
|
|
KR950703280A
(ko)
*
|
1992-09-09 |
1995-09-20 |
미리암 디.메코너헤이 |
제초성 벤젠 화합물(Herbicidal Benzene Compounds)
|
|
US5262564A
(en)
|
1992-10-30 |
1993-11-16 |
Octamer, Inc. |
Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
|
|
US5783599A
(en)
|
1993-02-24 |
1998-07-21 |
Octamer Inc |
Methods of treating cancer and viral infections with 5-iodo-6-amino-and 5-iodo-6-nitroso-1 2-benzopyrones
|
|
DZ1781A1
(fr)
|
1993-05-21 |
2002-02-17 |
Radopah Ltd |
Agents d'arylation.
|
|
JP3025602B2
(ja)
*
|
1993-05-21 |
2000-03-27 |
デビオファーム エス．アー． |
光学的に高純度なシス−オキザラート（トランス−ｌ−１，２−シクロヘキサンジアミン）白金（ＩＩ）錯体の製造方法
|
|
US6008250A
(en)
|
1993-05-26 |
1999-12-28 |
Bioresearch, Inc. |
Specific eatable taste modifiers
|
|
US6015792A
(en)
*
|
1993-05-26 |
2000-01-18 |
Bioresearch, Inc. |
Specific eatable taste modifiers
|
|
JPH06345723A
(ja)
*
|
1993-06-10 |
1994-12-20 |
Sumitomo Seika Chem Co Ltd |
メルカプトベンズアミドの製造法
|
|
JP3495072B2
(ja)
*
|
1993-12-29 |
2004-02-09 |
住友精化株式会社 |
１，２−ベンズイソチアゾール−３−オン類の製造方法
|
|
GB9404485D0
(en)
*
|
1994-03-09 |
1994-04-20 |
Cancer Res Campaign Tech |
Benzamide analogues
|
|
JP3720388B2
(ja)
*
|
1994-06-08 |
2005-11-24 |
住友精化株式会社 |
イソチアゾロン誘導体の製造方法
|
|
DE69513847T2
(de)
*
|
1994-10-17 |
2000-07-27 |
Novartis Ag, Basel |
Verfahren zur herstellung von substituierten 3-aminobenzonitrilen
|
|
JP3777455B2
(ja)
*
|
1994-11-24 |
2006-05-24 |
住友精化株式会社 |
芳香族またはヘテロ芳香族硫黄化合物の製造方法
|
|
US5589483A
(en)
*
|
1994-12-21 |
1996-12-31 |
Geron Corporation |
Isoquinoline poly (ADP-ribose) polymerase inhibitors to treat skin diseases associated with cellular senescence
|
|
GB9508538D0
(en)
*
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
|
JP3154399B2
(ja)
|
1996-07-04 |
2001-04-09 |
デビオファーム エス．アー． |
白金化合物の製造方法
|
|
IL123147A
(en)
|
1995-08-02 |
2004-02-19 |
Univ Newcastle Ventures Ltd |
Benzamide imidazole - 4 carboxamide and their use
|
|
GB9615619D0
(en)
|
1996-03-18 |
1996-09-04 |
Radopath Ltd |
Costimulation of TcR/CD3-induced T-Lymphocytes
|
|
US5837729A
(en)
|
1996-04-26 |
1998-11-17 |
Metatron, Inc. |
Methods for treating and preventing HIV infection using acetaminophen and derivatives thereof
|
|
US6017958A
(en)
*
|
1996-06-04 |
2000-01-25 |
Octamer, Inc. |
Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
|
|
US5736576A
(en)
*
|
1996-06-04 |
1998-04-07 |
Octamer, Inc. |
Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
|
|
US5981575A
(en)
|
1996-11-15 |
1999-11-09 |
Johns Hopkins University, The |
Inhibition of fatty acid synthase as a means to reduce adipocyte mass
|
|
GB9702701D0
(en)
|
1997-02-01 |
1997-04-02 |
Univ Newcastle Ventures Ltd |
Quinazolinone compounds
|
|
US20050287120A1
(en)
|
1997-03-21 |
2005-12-29 |
Fisher Paul B |
Cancer - targeted viral vectors
|
|
WO1998042328A1
(en)
*
|
1997-03-26 |
1998-10-01 |
Biosource Technologies, Inc. |
Di-aryl ethers and their derivatives as anti-cancer agents
|
|
ATE307797T1
(de)
|
1997-04-10 |
2005-11-15 |
Isotechnika Inc |
Aktivierte iod-verbindungen zur behandlung von krebs und aids
|
|
US5908861A
(en)
|
1997-05-13 |
1999-06-01 |
Octamer, Inc. |
Methods for treating inflammation and inflammatory disease using pADPRT inhibitors
|
|
US6426415B1
(en)
|
1997-09-03 |
2002-07-30 |
Guilford Pharmaceuticals Inc. |
Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
|
|
US6121278A
(en)
|
1997-09-03 |
2000-09-19 |
Guilford Pharmaceuticals, Inc. |
Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity
|
|
US6514983B1
(en)
*
|
1997-09-03 |
2003-02-04 |
Guilford Pharmaceuticals Inc. |
Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
|
|
US6235748B1
(en)
*
|
1997-09-03 |
2001-05-22 |
Guilford Pharmaceuticals Inc. |
Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
|
|
US5922775A
(en)
|
1997-10-23 |
1999-07-13 |
Octamer, Inc. |
Method of treating malignant tumors with ketone thyroxine analogues having no significant hormonal activity
|
|
US6380193B1
(en)
*
|
1998-05-15 |
2002-04-30 |
Guilford Pharmaceuticals Inc. |
Fused tricyclic compounds, methods and compositions for inhibiting PARP activity
|
|
JP2002515488A
(ja)
|
1998-05-15 |
2002-05-28 |
ギルフォード ファーマシューティカルズ インコーポレイテッド |
カルボキサミド化合物、組成物、及びｐａｒｐ活性の抑制方法
|
|
US6395749B1
(en)
*
|
1998-05-15 |
2002-05-28 |
Guilford Pharmaceuticals Inc. |
Carboxamide compounds, methods, and compositions for inhibiting PARP activity
|
|
CO5070700A1
(es)
|
1998-06-05 |
2001-08-28 |
Basf Ag |
Genes novedosos de (adp-ribosa) polimerasa
|
|
CN1331682A
(zh)
|
1998-11-03 |
2002-01-16 |
巴斯福股份公司 |
取代的2－苯基苯并咪唑类,其制备和用途
|
|
IL143303A0
(en)
|
1998-11-27 |
2002-04-21 |
Basf Ag |
Substituted benzimidazoles and their use as parp inhibitors
|
|
JP3552934B2
(ja)
|
1998-12-24 |
2004-08-11 |
セントラル硝子株式会社 |
安息香酸アミド類の製造方法
|
|
US6326517B1
(en)
|
1998-12-10 |
2001-12-04 |
Central Glass Company, Limited |
Method of producing benzamides
|
|
US6201020B1
(en)
*
|
1998-12-31 |
2001-03-13 |
Guilford Pharmaceuticals, Inc. |
Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
|
|
US6387902B1
(en)
*
|
1998-12-31 |
2002-05-14 |
Guilford Pharmaceuticals, Inc. |
Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
|
|
TR200102005T2
(tr)
|
1999-01-11 |
2001-12-21 |
Agouron Pharmaceuticals,Inc. |
Poli(adp-ribaz) polimerazların trisiklik inhibitörleri.
|
|
KR20010101675A
(ko)
*
|
1999-01-26 |
2001-11-14 |
우에노 도시오 |
2ｈ-프탈라진-1-온 유도체 및 그 유도체를 유효 성분으로하는 약제
|
|
US6423696B1
(en)
|
1999-04-16 |
2002-07-23 |
The United States Of America, As Represented By The Department Of Health & Human Services |
Inhibition of arylamine N-acetyl transferase
|
|
DE19921567A1
(de)
*
|
1999-05-11 |
2000-11-16 |
Basf Ag |
Verwendung von Phthalazine-Derivaten
|
|
US6653316B1
(en)
*
|
1999-05-19 |
2003-11-25 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
|
|
TWI262914B
(en)
*
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
|
GB9915995D0
(en)
|
1999-07-09 |
1999-09-08 |
Ahmed S |
Non-steroidal sulphamate compounds for use as oestrone sulphatase inhibitors
|
|
ECSP003637A
(es)
*
|
1999-08-31 |
2002-03-25 |
Agouron Pharma |
Inhibidores triciclicos de poli (adp-ribosa) polimerasas
|
|
US6803457B1
(en)
|
1999-09-30 |
2004-10-12 |
Pfizer, Inc. |
Compounds for the treatment of ischemia
|
|
US6562830B1
(en)
*
|
1999-11-09 |
2003-05-13 |
Cell Pathways, Inc. |
Method of treating a patient having precancerous lesions with phenyl quinazolinone derivatives
|
|
US6277990B1
(en)
|
1999-12-07 |
2001-08-21 |
Inotek Corporation |
Substituted phenanthridinones and methods of use thereof
|
|
US6476048B1
(en)
|
1999-12-07 |
2002-11-05 |
Inotek Pharamaceuticals Corporation |
Substituted phenanthridinones and methods of use thereof
|
|
US7122679B2
(en)
*
|
2000-05-09 |
2006-10-17 |
Cephalon, Inc. |
Multicyclic compounds and the use thereof
|
|
AU2001264595A1
(en)
*
|
2000-05-19 |
2001-12-03 |
Guilford Pharmaceuticals Inc. |
Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
|
|
AU1152702A
(en)
*
|
2000-10-12 |
2002-04-22 |
Merck & Co Inc |
Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
|
|
ITMI20002358A1
(it)
*
|
2000-10-31 |
2002-05-01 |
Flavio Moroni |
Derivati di tieno ,2, 3-c|isochinolin-3-one come inibitori della poli(a dp-ribosio)polimerasi
|
|
AUPR201600A0
(en)
*
|
2000-12-11 |
2001-01-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinazolinone derivative
|
|
DE10064423A1
(de)
|
2000-12-21 |
2002-07-04 |
Symyx Technologies Inc |
Verfahren zur Herstellung substituierter organischer Verbindungen und Verwendung von Katalysatoren für Substitutionsreaktionen
|
|
WO2002055076A1
(en)
|
2001-01-04 |
2002-07-18 |
Daiichi Pharmaceutical Co., Ltd. |
Cyclodextrin-containing pharmaceutical preparation
|
|
US20020142334A1
(en)
|
2001-01-30 |
2002-10-03 |
Brown Janice A. |
Methods of detecting poly(ADP-ribose) polymerase enzymatic activity
|
|
US20020164633A1
(en)
|
2001-04-20 |
2002-11-07 |
Inotek Pharmaceuticals Corporation |
Cell-based assay for detecting activation of poly (ADP-ribose) polymerase
|
|
EP1397350B1
(en)
|
2001-05-08 |
2007-02-28 |
Kudos Pharmaceuticals Limited |
Isoquinolinone derivatives as parp inhibitors
|
|
WO2003007955A2
(en)
|
2001-07-20 |
2003-01-30 |
Cancer Research Technology Limited |
Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
|
|
EP1423120A4
(en)
|
2001-08-15 |
2005-12-28 |
Icos Corp |
2H-PHTALAZINE-1-ONES AND METHODS OF USE THEREOF
|
|
US20050113283A1
(en)
*
|
2002-01-18 |
2005-05-26 |
David Solow-Cordero |
Methods of treating conditions associated with an EDG-4 receptor
|
|
AUPS019702A0
(en)
*
|
2002-01-29 |
2002-02-21 |
Fujisawa Pharmaceutical Co., Ltd. |
Condensed heterocyclic compounds
|
|
AUPS137402A0
(en)
|
2002-03-26 |
2002-05-09 |
Fujisawa Pharmaceutical Co., Ltd. |
Novel tricyclic compounds
|
|
CN100490817C
(zh)
|
2002-03-26 |
2009-05-27 |
万有制药株式会社 |
抗肿瘤吲哚并吡咯并咔唑衍生物和其它抗肿瘤药物联合用药
|
|
JPWO2003082808A1
(ja)
|
2002-04-03 |
2005-08-04 |
住友製薬株式会社 |
ベンズアミド誘導体
|
|
US20040034078A1
(en)
*
|
2002-06-14 |
2004-02-19 |
Agouron Pharmaceuticals, Inc. |
Benzimidazole inhibitors of poly(ADP-ribosyl) polymerase
|
|
JP2006508126A
(ja)
*
|
2002-11-06 |
2006-03-09 |
アザヤ セラピューティクス インコーポレイティッド |
薬学的製剤のタンパク質安定化されたリポソーム製剤
|
|
BRPI0408996A
(pt)
|
2003-03-31 |
2006-03-28 |
Pfizer |
saia de inibidores tricìclicos de poli(adpp-ribose) polimerases
|
|
ES2527871T3
(es)
*
|
2003-05-01 |
2015-02-02 |
Imclone Llc |
Anticuerpos completamente humanos dirigidos contra el receptor del factor de crecimiento 1 similar a la insulina humana
|
|
ES2396334T3
(es)
*
|
2003-05-28 |
2013-02-20 |
Eisai Inc. |
Compuestos, métodos y composiciones farmacéuticas para la inhibición de PARP
|
|
US20050004038A1
(en)
*
|
2003-06-27 |
2005-01-06 |
Lyon Robert P. |
Bivalent inhibitors of Glutathione-S-Transferases
|
|
PL1660095T3
(pl)
|
2003-07-25 |
2010-07-30 |
Cancer Research Tech Ltd |
Tricykliczne inhibitory PARP
|
|
US20050026933A1
(en)
*
|
2003-08-01 |
2005-02-03 |
Wyeth Holdings Corporation |
Use of a combination of an epidermal growth factor receptor kinase inhibitor and cytotoxic agents for treatment and inhibition of cancer
|
|
EP1663202A1
(en)
*
|
2003-09-04 |
2006-06-07 |
Aventis Pharmaceuticals, Inc. |
Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp)
|
|
WO2005023765A1
(en)
*
|
2003-09-11 |
2005-03-17 |
Pharmacia & Upjohn Company Llc |
Method for catalyzing amidation reactions by the presence of co2
|
|
MXPA06005686A
(es)
|
2003-11-20 |
2006-08-17 |
Janssen Pharmaceutica Nv |
2-quinolinonas y 2-quinoxalinonas 7-fenilaquilo sustituidas como inhibidores de la poli(adp-ribosa)polimerasa.
|
|
KR101118582B1
(ko)
|
2003-11-20 |
2012-02-27 |
얀센 파마슈티카 엔.브이. |
폴리(ａｄｐ-리보스)폴리머라제 저해제로서의 6-알케닐 및6-페닐알킬 치환된 2-퀴놀리논 및 2-퀴녹살리논
|
|
DK2305221T3
(en)
|
2003-12-01 |
2015-08-24 |
Kudos Pharm Ltd |
DNA damage repair inhibitors for the treatment of cancer
|
|
CA2546657C
(en)
|
2003-12-05 |
2013-05-14 |
Janssen Pharmaceutica N.V. |
6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
|
|
JP4948178B2
(ja)
|
2003-12-10 |
2012-06-06 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ポリ（ａｄｐ−リボース）ポリメラーゼ阻害剤としての置換６−シクロヘキシルアルキル置換２−キノリノンおよび２−キノキサリノン
|
|
US7439031B2
(en)
*
|
2003-12-15 |
2008-10-21 |
The Trustees Of The University Of Pennsylvania |
Method of identifying compounds that induce cell death by necrosis
|
|
US7680864B2
(en)
|
2004-03-02 |
2010-03-16 |
Intel Corporation |
Method and apparatus for managing access to stored objects based on retention policy
|
|
PE20060285A1
(es)
|
2004-03-30 |
2006-05-08 |
Aventis Pharma Inc |
Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
|
|
JP2005336083A
(ja)
|
2004-05-26 |
2005-12-08 |
Sumitomo Chemical Co Ltd |
芳香族アミノ化合物の製造方法
|
|
CN1980674B
(zh)
|
2004-06-30 |
2011-05-25 |
詹森药业有限公司 |
作为parp抑制剂的2,3-二氮杂萘衍生物
|
|
ES2415771T3
(es)
|
2004-06-30 |
2013-07-26 |
Janssen Pharmaceutica N.V. |
Derivados de quinazolina como inhibidores de PARP
|
|
EA012837B1
(ru)
|
2004-06-30 |
2009-12-30 |
Янссен Фармацевтика Н.В. |
Производные хиназолинона в качестве ингибиторов parp
|
|
US20060035890A1
(en)
|
2004-08-10 |
2006-02-16 |
Amit Banerjee |
Compounds and methods for the treatment of ubiquitin conjugating disorders
|
|
GB0419072D0
(en)
*
|
2004-08-26 |
2004-09-29 |
Kudos Pharm Ltd |
Phthalazinone derivatives
|
|
MX2007002461A
(es)
*
|
2004-09-22 |
2008-03-13 |
Pfizer |
Formas polimorficas y amorfas de la sal fosfato de 8-fluoro-2-{4-[metilamino)metil]fenil}-1, 3, 4, 5-tetrahidro-6h-azepino [5, 4, 3-cd]indol-6-ona.
|
|
EP1793830A2
(en)
|
2004-09-22 |
2007-06-13 |
Pfizer, Inc. |
Therapeutic combinations comprising poly(adp-ribose) polymerases inhibitor
|
|
DE102004050196A1
(de)
|
2004-10-15 |
2006-04-20 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 2-Pyridon-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
|
|
ATE479687T1
(de)
*
|
2004-10-15 |
2010-09-15 |
Takeda Pharmaceutical |
Kinaseinhibitoren
|
|
US20060094676A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Ronit Lahav |
Compositions and methods for treating cancer using compositions comprising an inhibitor of endothelin receptor activity
|
|
EP1813609B1
(en)
|
2004-10-29 |
2013-06-19 |
Msd K.K. |
Novel aminopyridine derivatives having selective aurora-a inhibitory effect
|
|
CN1768732A
(zh)
|
2004-11-02 |
2006-05-10 |
上海富海科申药业有限公司 |
芳香硝基化合物在制备治疗肿瘤药物中的应用
|
|
CN1768733A
(zh)
|
2004-11-02 |
2006-05-10 |
上海富海科申药业有限公司 |
芳香硝基化合物在制备治疗艾滋病药物中的应用
|
|
DE102005023834A1
(de)
|
2004-11-20 |
2006-05-24 |
Bayer Healthcare Ag |
Substituierte[(Phenylethanoyl)amino]benzamide
|
|
GB0428111D0
(en)
|
2004-12-22 |
2005-01-26 |
Kudos Pharm Ltd |
Pthalazinone derivatives
|
|
WO2006078503A2
(en)
|
2005-01-07 |
2006-07-27 |
Arqule, Inc. |
Compositions for modulation of parp and methods for screening for same
|
|
WO2006110683A1
(en)
|
2005-04-11 |
2006-10-19 |
Abbott Laboratories |
2-substituted-1h-benzimidazole-4-carboxamides are parp inhibitors
|
|
TWI375673B
(en)
|
2005-04-11 |
2012-11-01 |
Abbott Lab |
1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
|
|
CN101233121A
(zh)
*
|
2005-06-10 |
2008-07-30 |
彼帕科学公司 |
Parp调节剂和癌症的治疗
|
|
CN101242822B
(zh)
*
|
2005-07-18 |
2011-08-24 |
彼帕科学公司 |
治疗卵巢癌的药物
|
|
CN101370497B
(zh)
|
2006-01-17 |
2010-11-17 |
雅培制药有限公司 |
包含parp抑制剂和细胞毒性剂的联合产品及用途
|
|
US20080293795A1
(en)
|
2006-01-17 |
2008-11-27 |
Abbott Laboratories |
Combination therapy with parp inhibitors
|
|
WO2007107305A2
(en)
|
2006-03-22 |
2007-09-27 |
Medigene Ag |
Treatment of triple receptor negative breast cancer
|
|
US20080262062A1
(en)
|
2006-11-20 |
2008-10-23 |
Bipar Sciences, Inc. |
Method of treating diseases with parp inhibitors
|
|
CA2655257A1
(en)
|
2006-06-12 |
2008-12-04 |
Bipar Sciences, Inc. |
Method of treating diseases with parp inhibitors
|
|
US20100160442A1
(en)
*
|
2006-07-18 |
2010-06-24 |
Ossovskaya Valeria S |
Formulations for cancer treatment
|
|
DE102006037399A1
(de)
*
|
2006-08-10 |
2008-02-14 |
Archimica Gmbh |
Verfahren zur Herstellung von Arylaminen
|
|
AU2007292387A1
(en)
|
2006-09-05 |
2008-03-13 |
Bipar Sciences, Inc. |
Treatment of cancer
|
|
WO2008030892A2
(en)
|
2006-09-05 |
2008-03-13 |
Bipar Sciences, Inc. |
Drug design for tubulin inhibitors, compositions, and methods of treatment thereof
|
|
JP2010502731A
(ja)
*
|
2006-09-05 |
2010-01-28 |
バイパー サイエンシズ，インコーポレイティド |
Ｐａｒｐ阻害剤による脂肪酸合成の阻害、及びその治療方法
|
|
EP2059802A4
(en)
*
|
2006-09-05 |
2010-09-08 |
Bipar Sciences Inc |
METHODS FOR DESIGNING PARP INHIBITORS AND USES THEREOF
|
|
CN101190211B
(zh)
|
2006-11-23 |
2011-08-10 |
上海富海科申药业有限公司 |
芳香硝基化合物在制备治疗病毒性肝炎药物中的应用
|
|
EP3536690A1
(en)
|
2007-01-10 |
2019-09-11 |
MSD Italia S.r.l. |
Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
|
|
EP2121139B1
(en)
|
2007-01-16 |
2012-10-10 |
BiPar Sciences, Inc. |
Formulations for cancer treatment
|
|
ATE542799T1
(de)
|
2007-03-08 |
2012-02-15 |
Janssen Pharmaceutica Nv |
Chinolinonderivate als parp und tank-inhibitoren
|
|
JP2011500684A
(ja)
*
|
2007-10-19 |
2011-01-06 |
バイパー サイエンシズ，インコーポレイティド |
ベンゾピロン系ｐａｒｐ阻害剤を用いる癌の処置方法および組成物
|
|
KR20100102609A
(ko)
|
2007-11-12 |
2010-09-24 |
바이파 사이언스 인코포레이티드 |
Ｐａｒｐ 억제제를 단독으로 사용하거나 항종양제와 병용하여 유방암을 치료하는 방법
|
|
NZ586123A
(en)
*
|
2007-11-12 |
2012-12-21 |
Bipar Sciences Inc |
Treatment of ovarian cancer with 4-iodo-3-nitrobenzamide in combination with topoisomerase inhibitors
|
|
EP2224804A4
(en)
|
2007-12-07 |
2011-06-01 |
Bipar Sciences Inc |
TREATMENT OF CANCER WITH COMBINATIONS OF TOPOÎSOMERASE INHIBITORS AND PARP INHIBITORS
|
|
AU2009212401A1
(en)
|
2008-02-04 |
2009-08-13 |
Bipar Sciences, Inc. |
Methods of diagnosing and treating PARP-mediated diseases
|
|
EP2393364A4
(en)
|
2009-02-04 |
2013-03-13 |
Bipar Sciences Inc |
TREATMENT OF LUNG CANCER WITH A PARP INHIBITOR IN COMBINATION WITH A GROWTH FACTOR INHIBITOR
|